- Conditions
- Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Extreme Prematurity, Ventilator Lung; Newborn, Ventilation Perfusion Mismatch
- Interventions
- Increase in the PEEP followed by decrease in the PEEP, Decrease in the PEEP followed by increase in the PEEP
- Other
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 7 Days to 30 Days
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 846
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Infant,Premature
- Interventions
- Cardiorespiratory monitoring
- Diagnostic Test
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 1 Day to 98 Days
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Infant, Very Low Birth Weight
- Interventions
- Pasteurized human milk and pasteurized human milk fortifier, Human milk fortifier (bovine-based), pre-term formula, Pre-term/term formula
- Dietary Supplement
- Lead sponsor
- Prolacta Bioscience
- Industry
- Eligibility
- 1 Day to 21 Days
- Enrollment
- 260 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 12
- States / cities
- Berkeley, California • San Diego, California • New Haven, Connecticut + 9 more
- Conditions
- Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Infant, Premature, Intracranial Hemorrhages
- Interventions
- Vitamin E, Placebo
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 4 Hours
- Enrollment
- 93 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 12 more
- Conditions
- Intraventricular Hemorrhage of Prematurity
- Interventions
- Tortle Midliner
- Device
- Lead sponsor
- Orlando Health, Inc.
- Other
- Eligibility
- Up to 31 Weeks
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- Work of Breathing, Term Infant
- Interventions
- Work of breathing observation
- Other
- Lead sponsor
- Christiana Care Health Services
- Other
- Eligibility
- 1 Day to 1 Week
- Enrollment
- 31 participants
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Newark, Delaware
- Conditions
- Other Preterm Infants
- Interventions
- HCP will place the Invictus Cranial Support Device (CSD) on the patient, human intervention
- Device · Other
- Lead sponsor
- Invictus Medical, Inc.
- Industry
- Eligibility
- 30 Weeks to 36 Weeks
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Growth, Development
- Interventions
- assisted exercise, cuddle
- Other
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 30 Weeks to 35 Weeks
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Infection Associated With Catheter, Bacteremia, Sepsis
- Interventions
- Ethanol lock, Heparinized saline
- Drug
- Lead sponsor
- East Carolina University
- Other
- Eligibility
- Up to 32 Weeks
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2010
- U.S. locations
- 1
- States / cities
- Greenville, North Carolina
- Conditions
- Preterm Infant
- Interventions
- Early/Slow, Early/Fast, Late/Slow, Late/Fast
- Other
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Other
- Eligibility
- Up to 32 Weeks
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2012
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Retinopathy of Prematurity, ROP
- Interventions
- iROP DL
- Device
- Lead sponsor
- Siloam Vision
- Industry
- Eligibility
- 4 Weeks to 2 Years
- Enrollment
- 1,284 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Premature, Extremely Low Birth Weight Infants, Polyunsaturated Fatty Acid Levels
- Interventions
- LCPUFA supplement, placebo
- Dietary Supplement
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- Up to 72 Hours
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2016
- U.S. locations
- 3
- States / cities
- Chicago, Illinois • Evanston, Illinois
- Conditions
- Retinopathy of Prematurity (ROP)
- Interventions
- Ranibizumab
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 6 Months to 5 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2022
- U.S. locations
- 9
- States / cities
- Sacramento, California • Aurora, Colorado • Chicago, Illinois + 6 more
- Conditions
- Vitamin D Deficiency
- Interventions
- Placebo, 800 IU/day vitamin D supplementation with feedings in the first 28 days after birth, Usual Care
- Dietary Supplement · Other
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 24 Hours to 96 Hours
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Necrotizing Enterocolitis
- Interventions
- IBP-9414, Placebo
- Drug
- Lead sponsor
- Infant Bacterial Therapeutics
- Industry
- Eligibility
- Up to 48 Hours
- Enrollment
- 2,158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 54
- States / cities
- Tucson, Arizona • Little Rock, Arkansas • Loma Linda, California + 44 more
- Conditions
- Infant, Premature, Diseases
- Interventions
- Medolac human milk based human milk fortifier (MHMHMF)
- Dietary Supplement
- Lead sponsor
- Northwest Health
- Other
- Eligibility
- 23 Weeks to 32 Weeks
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 1
- States / cities
- Johnson, Arkansas
- Conditions
- Preterm Birth
- Interventions
- Sodium algorithm
- Procedure
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 25 Weeks to 30 Weeks
- Enrollment
- 6 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Retinopathy of Prematurity (ROP)
- Interventions
- FLQ-101
- Drug
- Lead sponsor
- FELIQS INC.
- Industry
- Eligibility
- 4 Days to 5 Days
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Iron-deficiency
- Interventions
- Iron Sulfate
- Drug
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Other
- Eligibility
- 7 Days to 4 Weeks
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Neurocognitive, Neuroprotective, Neonatal, Neurodevelopmental Impairment
- Interventions
- Darbepoetin, Placebo
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 650 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2025
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • Palo Alto, California • Atlanta, Georgia + 12 more
- Conditions
- Premature Baby 33 to 36 Weeks, Mother-Infant Interaction, Oxidative Stress
- Interventions
- Skin-to-skin
- Behavioral
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- Not listed
- Enrollment
- 8 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Neurodevelopmental Abnormality
- Interventions
- Randomized to Umbilical Cord Milking at birth, Randomized to Delayed Cord Clamping at birth
- Procedure
- Lead sponsor
- Sharp HealthCare
- Other
- Eligibility
- 22 Months to 42 Months
- Enrollment
- 1,200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Loma Linda, California • Los Angeles, California + 10 more
- Conditions
- Prematurity, Intestinal Permeability
- Interventions
- Lactulose -rhamnose solution
- Drug
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- Up to 4 Days
- Enrollment
- 211 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2021
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Problem With Growth of an Infant
- Interventions
- Powder protein modular, Liquid protein modular
- Dietary Supplement
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- Up to 40 Weeks
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska